![Loading Events](https://www.cvrc.virginia.edu/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
- This event has passed.
Natasha Sheybani, Phd
December 14, 2023 @ 11:00 am – 12:00 pm
![](https://i0.wp.com/www.cvrc.virginia.edu/wp-content/uploads/2023/11/NDS_2021headshot.jpeg?resize=400%2C400&ssl=1)
Immunoengineering Next-Generation Cancer Therapies with Focused Ultrasound
Despite the remarkable promise of cancer immunotherapy, a significant fraction of patients with solid tumors are yet unable to realize its unparalleled benefits. In this talk, I will introduce focused ultrasound (FUS) – a promising emerging technology for the non-invasive, non-ionizing, and precisely targeted deposition of acoustic energy into tumor tissues – as a strategy for immuno-modulation and immunotherapy delivery in primary and disseminated cancers of the brain and breast. I will provide an overview of (1) our pre-clinical work at the nexus of FUS, molecular imaging, and cancer immunotherapy and (2) the rich landscape for clinical translation of FUS immunotherapy paradigms here at UVA. Finally, I will highlight some of our emerging efforts to usher FUS into the era of precision medicine by leveraging advanced imaging, liquid biopsy, and artificial intelligence-driven approaches
Assistant Professor of Biomedical Engineering
Research Director, UVA Focused Ultrasound Cancer Immunotherapy Center, University of Virginia, Charlottesville, VA